<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="are among the most important complications in subjects affected by" exact="cancer" post="and/or in recipients of hematopoietic stem cell transplantation (HSCT)"/>
 <result pre="the onset of respiratory diseases in hematological patients such as" exact="influenza" post="(Flu) and parainfluenza virus (PiV), respiratory syncytial virus (RSV),"/>
 <result pre="herpes viruses [cytomegalovirus (CMV), Epstein-Barr virus (EBV), varicella-zoster virus (VZV)," exact="herpes simplex" post="1 and 2 (HSV1-2) and herpesvirus-6] frequently cause serious"/>
 <result pre="the epithelial cells of the upper airways [5]. The human" exact="influenza" post="virus belongs to the Orthomyxoviridae family, and its genome"/>
 <result pre="allow for the identification of different subtypes [2, 5]. Three" exact="influenza" post="virus genera are identified (A, B, C); influenza A"/>
 <result pre="5]. Three influenza virus genera are identified (A, B, C);" exact="influenza" post="A virus is divided into different subtypes on the"/>
 <result pre="period, and systemic use of corticosteroids [8]. The progression of" exact="influenza" post="virus to LRTI implies lymphopenia, the use of steroids"/>
 <result pre="an initial involvement of the upper respiratory tract: cough, rhinorrhea," exact="otitis media," post="wheezing, and sore throat with or without fever [4,"/>
 <result pre="without fever [4, 12]. Other less frequently observed symptoms are" exact="diarrhea" post="or gastrointestinal symptoms and conjunctivitis [9]. In other cases,"/>
 <result pre="less frequently observed symptoms are diarrhea or gastrointestinal symptoms and" exact="conjunctivitis" post="[9]. In other cases, as in influenza virus infection,"/>
 <result pre="gastrointestinal symptoms and conjunctivitis [9]. In other cases, as in" exact="influenza" post="virus infection, the typical manifestations may be absent [2]."/>
 <result pre="the most common community-acquired virus (47%) followed by PiV (14.1%)," exact="influenza" post="(11.2%), RSV (11.8%) and hMPV (8.8%) [8]. Viruses that"/>
 <result pre="only adults [20]Â (Table 2). Although the mortality rate for" exact="pneumonia" post="in healthy children and adults is low (0.5%), this"/>
 <result pre="D Pavilizumab Ribavirin aerosol Influenza 1.3â€&quot;40 8â€&quot;28 S, D Seasonal" exact="influenza" post="immunization Post-exposure prophylaxis with oseltamivir Oseltamivir Rhinovirus 2â€&quot;34 S,"/>
 <result pre="[22] â€&quot; HM hematological malignancy not otherwise specified, ALL acute" exact="lymphoid leukemia," post="AML acute myeloid leukemia The impact of RSV on"/>
 <result pre="hematological malignancy not otherwise specified, ALL acute lymphoid leukemia, AML" exact="acute myeloid leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
 <result pre="malignancy not otherwise specified, ALL acute lymphoid leukemia, AML acute" exact="myeloid leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
 <result pre="not otherwise specified, ALL acute lymphoid leukemia, AML acute myeloid" exact="leukemia" post="The impact of RSV on immunocompromised patients with myeloma"/>
 <result pre="respiratory tract [13, 21]. Mortality can reach 30% after developing" exact="pneumonia" post="[13]. Morbidity and mortality from this infection increase in"/>
 <result pre="infection increase in premature babies, and in children with underlying" exact="heart disease" post="or severe immunosuppression [16]. A single-center study [22] found"/>
 <result pre="of all episodes of respiratory viral infections in children with" exact="acute lymphoblastic leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
 <result pre="all episodes of respiratory viral infections in children with acute" exact="lymphoblastic leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
 <result pre="episodes of respiratory viral infections in children with acute lymphoblastic" exact="leukemia" post="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients"/>
 <result pre="(ALL). RSV infections occur in 0.3â€&quot;2.2% of pediatric patients with" exact="acute myeloid leukemia," post="14% of children with ALL [22] and 8.7% of"/>
 <result pre="RSV infections occur in 0.3â€&quot;2.2% of pediatric patients with acute" exact="myeloid leukemia," post="14% of children with ALL [22] and 8.7% of"/>
 <result pre="and 1% of lymphoma, respectively [1]. Influenza Virus (FLU) The" exact="influenza" post="virus is probably the most studied and known of"/>
 <result pre="carried out seroprevalence studies on their population with regard to" exact="influenza" post="A and B viruses: a prevalence of antibody levels"/>
 <result pre="for hematological patients [2]. A retrospective study, performed in two" exact="cancer" post="centers in the USA and Mexico on hematological patients"/>
 <result pre="in the USA and Mexico on hematological patients hospitalized for" exact="influenza" post="symptoms between 2009 and 2014 (during the AH1N1 pandemic"/>
 <result pre="(range 1â€&quot;88)Â years and that the majority of patients had" exact="leukemia" post="(54%). Besides, 42% of hospitalized patients developed LRTI and"/>
 <result pre="in HSCT patients to be 6.3% [2]. The incidence of" exact="influenza" post="in hematological and/or transplant patients varies, according to the"/>
 <result pre="about 36% [22] and 38% [5] of respiratory infections. Notaby," exact="influenza" post="is highly variable in terms of both genome (antigenic"/>
 <result pre="risk of complications and death [28]. In patients with myeloma," exact="influenza" post="is the respiratory virus associated with the greatest morbidity"/>
 <result pre="the greatest morbidity and mortality, and their risk of developing" exact="influenza" post="is approximately six times higher than in controls [10]."/>
 <result pre="patients affected by a respiratory virus had a diagnosis of" exact="leukemia" post="or lymphoma (LL). hRV was the most detected virus"/>
 <result pre="by a respiratory virus had a diagnosis of leukemia or" exact="lymphoma" post="(LL). hRV was the most detected virus in all"/>
 <result pre="(hematological, with solid tumor or post-HSCT). In patients affected by" exact="leukemia" post="or lymphoma and by a viral infection, hRV was"/>
 <result pre="solid tumor or post-HSCT). In patients affected by leukemia or" exact="lymphoma" post="and by a viral infection, hRV was detected in"/>
 <result pre="isolated pathogen (33% of cases) in respiratory infections in pediatric" exact="cancer" post="patients [33.9% in acute lymphoblastic leukemia (ALL) and acute"/>
 <result pre="cases) in respiratory infections in pediatric cancer patients [33.9% in" exact="acute lymphoblastic leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
 <result pre="in respiratory infections in pediatric cancer patients [33.9% in acute" exact="lymphoblastic leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
 <result pre="respiratory infections in pediatric cancer patients [33.9% in acute lymphoblastic" exact="leukemia" post="(ALL) and acute myeloid leukemia (AML) and 31.8% in"/>
 <result pre="pediatric cancer patients [33.9% in acute lymphoblastic leukemia (ALL) and" exact="acute myeloid leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
 <result pre="cancer patients [33.9% in acute lymphoblastic leukemia (ALL) and acute" exact="myeloid leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
 <result pre="patients [33.9% in acute lymphoblastic leukemia (ALL) and acute myeloid" exact="leukemia" post="(AML) and 31.8% in solid tumors] [12]. A study"/>
 <result pre="total patients with hRV (110) were affected by ALL or" exact="myelodysplastic syndrome" post="(MDS), 19% by chronic leukemia, and 49% by lymphoma,"/>
 <result pre="syndrome (MDS), 19% by chronic leukemia, and 49% by lymphoma," exact="multiple myeloma" post="(MM) or other. In addition, 45% of these patients"/>
 <result pre="was identified as the second most frequent cause of idiopathic" exact="pneumonia" post="(12% of the detected pathogens) [2]. Fisher et al."/>
 <result pre="around 40% of HSCT patients with documented hRV infection developed" exact="pneumonia" post="and 60% of them had co-infections [35]. Viruses belonging"/>
 <result pre="more recent review highlighted that 7% of all children with" exact="cancer" post="who developed a respiratory infection were positive for hMPV."/>
 <result pre="[39]; according to a 2016 review, ALL is the hematological" exact="neoplasm" post="most frequently associated with this virus. For adults this"/>
 <result pre="and 50% [6] and can reach 17% in patients with" exact="pneumonia" post="[2]. However, no statistically significant differences between HSCT and"/>
 <result pre="RSV infection. Of the 18 CMV/RSV co-infections, 11 developed severe" exact="pneumonia" post="(68% of cases), while the same happened in only"/>
 <result pre="RSV infection. Five HSTC patients (approximately 7%) died of severe" exact="pneumonia" post="[17]. Seropositivity for CMV or reactivation of the same"/>
 <result pre="[6]. A prospective study carried out on children diagnosed with" exact="cancer" post="showed that hBoV was present in 8% of viral"/>
 <result pre="[2]. In contrast to the low incidence of bronchitis and" exact="pneumonia" post="in healthy children, severe clinical pictures have been mainly"/>
 <result pre="an observational retrospective study conducted in immunocompromised patients with viral" exact="lung disease" post="showed that the results of PCR tests performed on"/>
 <result pre="In patients with myeloma, oseltamivir reduces the risk of developing" exact="pneumonia" post="as well as relapses [13], while a delay in"/>
 <result pre="not recommended [13]. Ribavirin therapy is recommended in patients with" exact="leukemia" post="and patients with HSCT at high risk of complications"/>
 <result pre="the 2013 Infectious Diseases Society of America Guidelines, an intramuscular" exact="influenza" post="vaccine is recommended for all immunocompromised patients and HSCT"/>
 <result pre="in contact with the patient [43]. Even in patients with" exact="multiple myeloma," post="an effective preventive strategy to reduce the risk of"/>
 <result pre="myeloma, an effective preventive strategy to reduce the risk of" exact="influenza" post="is represented by the seasonal influenza immunization. Although patients"/>
 <result pre="reduce the risk of influenza is represented by the seasonal" exact="influenza" post="immunization. Although patients with multiple myeloma are known to"/>
 <result pre="is represented by the seasonal influenza immunization. Although patients with" exact="multiple myeloma" post="are known to not have high levels of specific"/>
 <result pre="such as DAS 181 on mortality or on progression to" exact="pneumonia" post="has yet to be determined [5]. Lastly, immunotherapy for"/>
 <result pre="yet to be determined [5]. Lastly, immunotherapy for RSV and" exact="influenza" post="has so far given promising results [5]. As previously"/>
 <result pre="given promising results [5]. As previously stated, infections caused by" exact="influenza" post="virus have been successfully treated with neuramidase inhibitors (oseltamivir);"/>
 <result pre="successfully treated with neuramidase inhibitors (oseltamivir); however, its efficacy for" exact="influenza" post="pneumonia has not been established, and antiviral resistance frequently"/>
 <result pre="treated with neuramidase inhibitors (oseltamivir); however, its efficacy for influenza" exact="pneumonia" post="has not been established, and antiviral resistance frequently occurs"/>
 <result pre="J Hematol Infect Dis2019111e201900610.4084/mjhid.2019.00630671212 5.HijanoDRMaronGHaydenRTRespiratory viral infections in patients with" exact="cancer" post="or undergoing hematopoietic cell transplantFront Microbiol201810.3389/fmicb.2018.0309730619176 6.FontanaLStrasfeldLRespiratory virus infections"/>
 <result pre="epidemiology of acute respiratory viral infections in pediatric patients with" exact="cancer" post="undergoing chemotherapyJ. Pediatr. Hematol. Oncol.2019414e242e24610.1097/MPH.000000000000141830688827 13.TehBWSlavinMAHarrisonSJWorthLJPrevention of viral infections"/>
 <result pre="patientsPediatr Transplant20151919410010.1111/petr.1238325377237 17.YueCet al.Virus infection facilitates the development of severe" exact="pneumonia" post="in transplant patients with hematologic malignanciesOncotarget2016733539305394010.18632/oncotarget.1018227340772 18.HatanakaMet al.Respiratory syncytial"/>
 <result pre="parainfluenza virus type 3 in adults receiving treatment for either" exact="acute leukemia" post="or severe aplastic anemia: a retrospective single center studyAnn"/>
 <result pre="virus type 3 in adults receiving treatment for either acute" exact="leukemia" post="or severe aplastic anemia: a retrospective single center studyAnn"/>
 <result pre="acute lymphoblastic leukemiaCancer2016122579880510.1002/cncr.2983326700662 23.BenitesECAet al.Acute respiratory viral infections in pediatric" exact="cancer" post="patients undergoing chemotherapyJ. Pediatr.201490437037610.1016/j.jped.2014.01.006 24.SauerbreiAet al.Prevalence of antibodies against"/>
 <result pre="cancer patients undergoing chemotherapyJ. Pediatr.201490437037610.1016/j.jped.2014.01.006 24.SauerbreiAet al.Prevalence of antibodies against" exact="influenza" post="A and B viruses in children in Germany, 2008â€&quot;2010Eurosurveillance2008195201410.2807/1560-7917.ES2014.19.5.20687"/>
 <result pre="and B viruses in children in Germany, 2008â€&quot;2010Eurosurveillance2008195201410.2807/1560-7917.ES2014.19.5.20687 25.AlsuwaidiARAl-MekainiLAKamalSMNarchiHSouidAKSeroprevalence of" exact="influenza" post="A and B viruses among unvaccinated children in the"/>
 <result pre="al.Influenza in patients with hematological malignancies: experience at two comprehensive" exact="cancer" post="centersJ Med Virol2018901506010.1002/jmv.2493028851056 27.NicholsWGGuthrieKACoreyLBoeckhMInfluenza infections after hematopoietic stem cell"/>
 <result pre="a systematic reviewCancer Lett2016370235836410.1016/j.canlet.2015.11.01426582658 41.ChoiS-MBoudreaultAAXieHEnglundJACoreyLBoeckhMDifferences in clinical outcomes after 2009" exact="influenza" post="A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsBlood2011117195050505610.1182/blood-2010-11-31918621372154"/>
 <result pre="41.ChoiS-MBoudreaultAAXieHEnglundJACoreyLBoeckhMDifferences in clinical outcomes after 2009 influenza A/H1N1 and seasonal" exact="influenza" post="among hematopoietic cell transplant recipientsBlood2011117195050505610.1182/blood-2010-11-31918621372154 42.HicksKLChemalyRFKontoyiannisDPCommon community respiratory viruses"/>
</results>
